International Clinical Trial: Cannabidiol (CBD) for Irritability and Aggression in Autism Spectrum Disorder (ASD): A Phase 2 Study

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12625001088437) titled 'Cannabidiol (CBD) for Irritability and Aggression in Autism Spectrum Disorder (ASD): A Phase 2 Study' on Oct. 7.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used)

Primary Sponsor: NeuroElevate Biosciences

Condition: Autism Spectrum Disorder Autism Spectrum Disorder Mental Health - Autistic spectrum disorders

Intervention: The trial consists of two phases: Randomized, Double-Blind, Placebo-Controlled Phase (Weeks 0-12) with 3 treatment arms: Arm 1: CBD 20 mg/kg/day (10 mg/kg taken orally twice daily, BD) Arm 2: CBD 10 mg/kg...